We research how chromatin modifications shape nuclear events including replication and transcriptional silencing, and their consequences on aging, carcinogenesis, and development. We are also interested in chromatin as a therapeutic target in cancer and other diseases that exhibit chromatin dysregulation.
Are you interested in joining the Bedalov Lab? Information on how to apply, whether as an undergraduate intern, graduate student, or postdoctoral fellow can be found here.
Featured on the front page of the Fred Hutch website, the Hutch News service wrote a feature highlighting our paper about Rett syndrome targets identified in a screen for reactivating MECP2 on the inactive X-chromosome.
We've published two papers in PNAS to kick 2017 off:
PDFs can also be found here.